No products in the cart.
mRNA Covid-19 vaccine safe and efficacious in 5-to-11-year-old children
1. BNT162b2 mRNA Covid-19 vaccine was efficacious in preventing symptomatic Covid-19 in children 5 to 11 years of age. 2. ...
Tag: covid vaccine
#VisualAbstract: Adequate antibody response to mRNA-1273 COVID-19 vaccine occurs in patients with cancer
1. The majority of patients being treated for solid tumour cancers were adequate responders to the vaccine. 2. Serious adverse ...
BNT162b2 COVID-19 vaccine may reduce hospitalizations from SARS-CoV-2 delta variant for up to six months
1. Despite waning effectiveness against SARS-CoV-2 infection, fully vaccinated patients continued to show low COVID-19 hospitalization rates up to 5 ...
Increasing the number of SARS-CoV-2 immune family members associated with decreasing risk of infection in nonimmune individuals
1. Individuals not immune to COVID-19 had at least a 45% decreased risk of COVID-19 infection if at least one ...
Patients with a previous allergy history and women are at increased risk of rare anaphylactic reaction to mRNA COVID-19 vaccines
1. A case series of 22 patients found that women and patients with an allergy history were more likely to ...
Third dose of ChAdOx1 nCoV-19 vaccine and prolonged second dose-intervals are both associated with increased antibody titers
1. An interval of 44-45 weeks between the first and second dose resulted in a four-fold increase in median antibody ...
Heterologous ChAdOx1 prime-boosted vaccination schedules are non-inferior to homologous vaccination
1. Heterologous AstraZeneca followed by Pfizer vaccination was noninferior to homologous, two-dose AstraZeneca vaccination with a geometric mean ratio of ...
National survey reports parental views on COVID-19 vaccination in children
1. In a large national survey, more than half of U.S. parents reported hesitancy in vaccinating their children against COVID-19. ...
Interim analysis of rates of adverse events following COVID-19 mRNA vaccination
1. An interim analysis of post-vaccination surveillance data for individuals who had received either Pfizer or Moderna mRNA COVID-19 vaccinations ...
Poor humoral response observed in patients undergoing hemodialysis following a single dose of the BNT162b2 SARS-CoV-2 vaccine
1. The findings of this prospective cohort study suggested poor humoral immune response following a single dose of the BNT162b2 ...
